Fagron completed the acquisition of Letco Medical for $34m.

Fagron, a pharmaceutical compounding company, completed the acquisition of Letco Medical, a supplier of pharmaceutical raw materials, supplies and equipment, for $34m. "We are very pleased to acquire Letco. Together, our companies will form a strong combination with a broad product portfolio, a strong customer base and excellent growth opportunities. With the acquisition of Letco, Fagron strengthens its position in Brands & Essentials in the United States. This brings us a step closer to realizing our ambition to be the market leader in this segment in the countries where we operate. We look forward to welcoming the Letco employees to the Fagron family. At the same time, the divestment of our contract manufacturing business accelerates our focus on creating the future of personalizing medicine," Rafael Padilla, Fagron CEO.